Daventry Pharma Limited - Accounts to registrar (filleted) - small 18.2
Daventry Pharma Limited - Accounts to registrar (filleted) - small 18.2
| REGISTERED NUMBER: |
| Daventry Pharma Limited |
| Unaudited Financial Statements for the Year Ended 28 February 2021 |
| Daventry Pharma Limited (Registered number: 06089986) |
| Contents of the Financial Statements |
| for the Year Ended 28 February 2021 |
| Page |
| Balance Sheet | 1 |
| Notes to the Financial Statements | 3 |
| Daventry Pharma Limited (Registered number: 06089986) |
| Balance Sheet |
| 28 February 2021 |
| 2021 | 2020 |
| Notes | £ | £ |
| FIXED ASSETS |
| Tangible assets | 4 |
| Investment property | 5 |
| CURRENT ASSETS |
| Stocks |
| Debtors | 6 |
| Cash at bank and in hand |
| CREDITORS |
| Amounts falling due within one year | 7 | ( |
) | ( |
) |
| NET CURRENT ASSETS |
| TOTAL ASSETS LESS CURRENT LIABILITIES |
| CREDITORS |
| Amounts falling due after more than one year |
8 |
( |
) |
( |
) |
| NET ASSETS |
| CAPITAL AND RESERVES |
| Called up share capital |
| Retained earnings |
| The directors acknowledge their responsibilities for: |
| (a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
| (b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company. |
| Daventry Pharma Limited (Registered number: 06089986) |
| Balance Sheet - continued |
| 28 February 2021 |
| In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered. |
| The financial statements were approved by the Board of Directors and authorised for issue on |
| Daventry Pharma Limited (Registered number: 06089986) |
| Notes to the Financial Statements |
| for the Year Ended 28 February 2021 |
| 1. | STATUTORY INFORMATION |
| Daventry Pharma Limited is a |
| Registered number: | 06089986 |
| Registered office: | 89 Lutterworth road |
| Nuneaton |
| CV11 6QA |
| 2. | ACCOUNTING POLICIES |
| Basis of preparing the financial statements |
| Turnover |
| Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. |
| Tangible fixed assets |
| Freehold property | - |
| Plant and machinery | - |
| Government grants |
| Government small business support and NHS grants were received during the year and recognised in other operating income. |
| Investment property |
| Investment property is shown at most recent valuation. Any aggregate surplus or deficit arising from changes in fair value is recognised in profit or loss. |
| Stocks |
| Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items. |
| Taxation |
| Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date. |
| Pension costs and other post-retirement benefits |
| The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate. |
| 3. | EMPLOYEES AND DIRECTORS |
| The average number of employees during the year was |
| Daventry Pharma Limited (Registered number: 06089986) |
| Notes to the Financial Statements - continued |
| for the Year Ended 28 February 2021 |
| 4. | TANGIBLE FIXED ASSETS |
| Freehold | Plant and |
| property | machinery | Totals |
| £ | £ | £ |
| COST |
| At 29 February 2020 |
| Additions |
| At 28 February 2021 |
| DEPRECIATION |
| At 29 February 2020 |
| Charge for year |
| At 28 February 2021 |
| NET BOOK VALUE |
| At 28 February 2021 |
| At 28 February 2020 |
| 5. | INVESTMENT PROPERTY |
| Total |
| £ |
| FAIR VALUE |
| At 29 February 2020 |
| and 28 February 2021 |
| NET BOOK VALUE |
| At 28 February 2021 |
| At 28 February 2020 |
| 6. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
| 2021 | 2020 |
| £ | £ |
| Trade debtors |
| Other debtors |
| 7. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
| 2021 | 2020 |
| £ | £ |
| Bank loans and overdrafts |
| Trade creditors |
| Taxation and social security |
| Other creditors |
| Daventry Pharma Limited (Registered number: 06089986) |
| Notes to the Financial Statements - continued |
| for the Year Ended 28 February 2021 |
| 8. | CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR |
| 2021 | 2020 |
| £ | £ |
| Bank loans |
| Amounts falling due in more than five years: |
| Repayable by instalments |
| Bank loans more 5 yr by instal | 782,508 | 800,296 |
| 9. | ULTIMATE CONTROLLING PARTY |
| In the opinion of the directors the company is jointly controlled by Mr M Azim and Mr T Esan. |